Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
1.
Am J Hematol ; 64(1): 71-2, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10815792

RESUMO

In a double-blinded placebo-controlled trial of folic acid supplementation in 82 alcoholic subjects, it was found that whole blood folate levels, determined by a mass spectrometric method, do not increase in subjects whose baseline folate levels are above the third quartile (folate sufficiency). Since a state of folate sufficiency can now be identified, a recommended daily allowance (RDA) for folate can be determined using objective means.


Assuntos
Alcoolismo , Deficiência de Ácido Fólico/tratamento farmacológico , Ácido Fólico/administração & dosagem , Ácido Fólico/sangue , Hematínicos/administração & dosagem , Hematínicos/sangue , Administração Oral , Adulto , Método Duplo-Cego , Feminino , Deficiência de Ácido Fólico/sangue , Humanos , Masculino
2.
J Chromatogr A ; 862(2): 161-8, 1999 Nov 12.
Artigo em Inglês | MEDLINE | ID: mdl-10596973

RESUMO

The oxidation and reduction of glutathione and oxidized glutathione were studied in real time by liquid chromatography-mass spectrometry during exposure to hydrogen peroxide and mercaptoethanol. By mass spectrometry mixed disulfides and both reversible and irreversible oxidations of sulfur to higher states (sulfinic and sulfonic acids) were directly observed during exposure to hydrogen peroxide. The irreversible oxidation of glutathione to glutathione sulfonic acid could be detected after 30 min exposure of glutathione to 40 mM H2O2 at 20 degrees C. A peak consistent with glutathione-sulfinic acid was transiently present, suggesting this compound behaved as an oxygen consuming antioxidant. Liquid chromatography-mass spectrometry appears to be an excellent method to study oxidation and reductions of sulfur containing peptides and amino acids.


Assuntos
Glutationa/química , Cromatografia Líquida , Concentração de Íons de Hidrogênio , Espectrometria de Massas , Oxirredução , Enxofre/química
6.
Eur J Clin Nutr ; 51(3): 188-92, 1997 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9076410

RESUMO

OBJECTIVE: To determine if changes in serum homocysteine values during folic acid supplementation can identify objectively healthy subjects with subclinical folate deficiency. DESIGN: Blood drawn and processed in a regimented fashion from fasting subjects. Serum homocysteine values determined by gas chromatography-mass spectrometry twice before and on days 5 and 8 of daily folic acid supplementation. SETTING: Outpatient University Hospital Clinical Research Center, Denver, Colorado. SUBJECTS: Subjectively healthy adults with normal hematologic and biochemical screening tests. INTERVENTION: Folic acid 1 mg daily for eight consecutive days. RESULTS: Homocysteine values of the group fell significantly during folic acid supplementation. Values pre supplementation were 7.8 +/- 1.8 and 7.4 +/- 2.4 mumol/L while values on days 5 and 8 of supplementation were 6.5 +/- 2.2 and 6.3 +/- 2.2 mumol/L. However, the homocysteine values of any given individual varied up to 60% (rises up to 7 mumol/L and falls of 5 mumol/L) during folic acid supplementation despite the controlled circumstances of blood handling, and an assay coefficient of variation of 8%. CONCLUSIONS: Although group values of serum homocysteine fall during folic acid supplementation, intraindividual variation is so great that subjects with subclinical folate deficiency can not be identified using this study design. Furthermore, these data suggest than an individuals homocysteine values vary enough that single values must be interpreted with caution.


Assuntos
Ácido Fólico/administração & dosagem , Homocisteína/sangue , Adolescente , Adulto , Idoso , Feminino , Ácido Fólico/sangue , Deficiência de Ácido Fólico/diagnóstico , Deficiência de Ácido Fólico/tratamento farmacológico , Cromatografia Gasosa-Espectrometria de Massas , Humanos , Masculino , Pessoa de Meia-Idade , Vitamina B 12/sangue
8.
J Chromatogr B Biomed Appl ; 677(1): 147-51, 1996 Feb 23.
Artigo em Inglês | MEDLINE | ID: mdl-8925087

RESUMO

A new stable isotope dilution gas chromatograph-mass spectrometric method of analysis of homogentisic acid is described. Using this method, homogentisic acid is measured for the first time in normal human plasma. The assay of sera from nine normal individuals yielded a range of values from 2.4 to 12 ng/ml. The method appears to be very sensitive and may be useful in the characterization of heterozygotes for alkaptonuria and other disorders of tyrosine degradation.


Assuntos
Ácido Homogentísico/sangue , Alcaptonúria/sangue , Alcaptonúria/genética , Erros Inatos do Metabolismo dos Aminoácidos/sangue , Erros Inatos do Metabolismo dos Aminoácidos/genética , Cromatografia Gasosa-Espectrometria de Massas , Heterozigoto , Humanos , Técnica de Diluição de Radioisótopos , Tirosina/metabolismo
10.
Am J Gastroenterol ; 90(12): 2182-5, 1995 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8540512

RESUMO

OBJECTIVE: To determine if a single-step noninvasive stable isotope method of assessing digestive function could separate normal subjects from subjects with pancreatic insufficiency (maldigestion) or small bowel dysfunction (malabsorption) and to see if subjects with maldigestion could be simultaneously separated from subjects with malabsorption. METHODS: Forty (40) normal volunteers, 18 adults with cystic fibrosis and four adults with celiac sprue, ingested a liquid test meal along with bentiromide, [13C6]PABA, and xylose (PABAX test). Serum was collected at 1 h and analyzed for PABA, [13C6]PABA, and xylose by stable isotope dilution methods using gas chromatography mass spectrometry. RESULTS: All subjects with cystic fibrosis had abnormal pancreatic function test results, whereas three of four adults with sprue had normal values of pancreatic function. All subjects with sprue had abnormal small bowel absorption tests, whereas all adults with cystic fibrosis had apparently normal intestinal function. CONCLUSION: The one-step, 1-h PABAX test can reliably separate normal subjects from those with either maldigestion or malabsorption and can also separate subjects with maldigestion from those with malabsorption.


Assuntos
Insuficiência Pancreática Exócrina/diagnóstico , Intestino Delgado/metabolismo , Síndromes de Malabsorção/diagnóstico , Pâncreas/fisiopatologia , Ácido 4-Aminobenzoico , Absorção , Adulto , Isótopos de Carbono , Doença Celíaca/diagnóstico , Fibrose Cística/diagnóstico , Diagnóstico Diferencial , Insuficiência Pancreática Exócrina/fisiopatologia , Humanos , Enteropatias/diagnóstico , Enteropatias/fisiopatologia , Síndromes de Malabsorção/fisiopatologia , Valores de Referência , Xilose , para-Aminobenzoatos
11.
Anal Biochem ; 225(1): 1-9, 1995 Feb 10.
Artigo em Inglês | MEDLINE | ID: mdl-7778757

RESUMO

We report a new gas chromatography-mass spectrometry (GC-MS) method of measurement of red blood cell folates utilizing a stable isotope-labeled bacterial synthesized folate internal standard. The GC-MS method exploits the fact that the common feature of all folate molecules is a p-aminobenzoic acid moiety sandwiched between a pteridine ring and a polyglutamate chain of varying length. In this method, red blood cell folates together with a folate internal standard are specifically purified using bovine folate binding protein and the folates are subsequently chemically cleaved to p-aminobenzoic acid, pteridines, and glutamic acids. Since all six carbon atoms of the benzene ring in the p-aminobenzoic acid moiety of the folate internal standard are labeled with [13C], it is possible to use selected ion monitoring and stable isotope dilution GC-MS to quantitate folates. The method appears to be sensitive, specific, and accurate. The method has been applied to generate a reference range of red blood cell folates based on assay of 25 normal individuals.


Assuntos
Eritrócitos/química , Ácido Fólico/sangue , Receptores de Superfície Celular , Ácido 4-Aminobenzoico/metabolismo , Animais , Isótopos de Carbono , Proteínas de Transporte/metabolismo , Bovinos , Receptores de Folato com Âncoras de GPI , Ácido Fólico/biossíntese , Cromatografia Gasosa-Espectrometria de Massas/métodos , Humanos , Marcação por Isótopo/métodos , Lactobacillus/metabolismo , Padrões de Referência , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
12.
Am J Clin Pathol ; 102(5): 595-9, 1994 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-7942623

RESUMO

A gas chromatography/mass spectrometric (GC/MS) isotope dilution assay for xylose was developed using tertbutyldimethylsilyl-derivatized xylose and [13C]1xylose, and applied to human serum samples. A calibration curve in serum using this assay showed < 3% variation (< 10 mg/L) for any given point. The correlation coefficient for xylose measurements made on 27 sera between a colorimetric method performed by a national commercial reference laboratory and the GC/MS method developed here was .952. However, xylose determinations of 10 of 27 samples differed by > 10% (up to 150 mg/L) when colorimetric values were compared to GC/MS. Two of these samples had borderline-low xylose values by GC/MS, but were well within the normal range by colorimetric analysis. gas chromatography/mass spectrometric isotope dilution assay appears to be an accurate method to measure xylose in serum. These data also suggest that further prospective studies comparing GC/MS to colorimetric methods are indicated for subjects undergoing oral xylose testing.


Assuntos
Cromatografia Gasosa-Espectrometria de Massas/métodos , Xilose/sangue , Colorimetria/métodos , Humanos , Estrutura Molecular , Sensibilidade e Especificidade , Xilose/química
13.
Med Hypotheses ; 43(4): 239-44, 1994 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7838008

RESUMO

Folate, cobalamin and pyridoxine deficiency are associated with psychiatric or neurological symptomatology. Disturbances in sulfur amino acid metabolism leading to accumulation of homocysteine occurs in all three conditions as the metabolism of homocysteine depends on enzymes requiring these vitamins as cofactors. Oxidation products of homocysteine (homocysteine sulfinic acid and homocysteic acid) and cysteine (cysteine sulfinic acid and cysteic acid) are excitatory sulfur amino acids and may act as excitatory neurotransmitters, whereas taurine and hypotaurine (decarboxylation products of cysteic acid and cysteine sulfinic acid) may act as inhibitory transmitters. Homocysteic acid and cysteine sulfinic acid have been considered as endogenous ligands for the N-methyl-D-aspartate (NMDA) type of glutamate receptors. The profile of these sulfur amino acid neurotransmitters could be altered in a similar fashion in states of decreased availability of folate, cobalamin or pyridoxine. It is proposed that the mechanism of neuropsychiatric manifestations in all three conditions result from a combination of two insults to homocysteine catabolism in the brain.


Assuntos
Aminoácidos Sulfúricos/metabolismo , Encefalopatias/etiologia , Aminoácidos Excitatórios/metabolismo , Deficiência de Ácido Fólico/complicações , Transtornos Mentais/etiologia , Deficiência de Vitamina B 12/complicações , Deficiência de Vitamina B 6/complicações , Encéfalo/metabolismo , Humanos , Receptores de N-Metil-D-Aspartato/metabolismo
14.
Anal Biochem ; 220(2): 249-56, 1994 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-7978266

RESUMO

Oxidized sulfur-containing amino acids are recognized as agonists of excitatory amino acid receptors in the mammalian nervous system. Homologues of glutamic acid (homocysteine sulfinic acid and homocysteic acid) and aspartic acid (cysteine sulfinic acid and cysteic acid) have been shown to be agonistic to N-methyl-D-aspartate receptors in animal brain and have been demonstrated in brain tissue. Considerable evidence exists for the role of homocysteic acid and cysteine sulfinic acid as endogenous ligands for excitatory amino acid receptors. We report, for the first time, the quantitation of these compounds in normal human serum, by a newly developed gas chromatography-mass spectrometry method that employs stable isotope-dilution selected ion monitoring using internal standards prepared in our laboratory. We also report new methods of synthesis of stable isotope-labeled internal standards used in measuring cysteine sulfinic acid, cysteic acid, homocysteine sulfinic acid, and homocysteic acid.


Assuntos
Ácido Cisteico/sangue , Cisteína/análogos & derivados , Homocisteína/análogos & derivados , Ácido Aspártico/sangue , Cisteína/sangue , Deutério , Cromatografia Gasosa-Espectrometria de Massas/métodos , Homocisteína/sangue , Humanos , Marcação por Isótopo/métodos , Neurotransmissores , Valores de Referência
15.
Clin Pediatr (Phila) ; 33(6): 340-3, 1994 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-8200167

RESUMO

Six hundred sixty-three children aged 1 to 16 years with thrombocytosis (defined as a platelet count of more than 500 x 10(9)/L) seen in a university hospital over a 1-year period were studied prospectively for etiology. The causes of thrombocytosis were infection (30.6%), hemolytic anemia (19.3%), tissue damage (15.2%), rebound thrombocytosis (14.8%), chronic inflammation (4.1%), renal disorders (4.1%), and malignancy (2%). Thrombocytosis associated with multiple, simultaneous causative factors was seen in 3.3% of cases. Among all patients with infections, osteomyelitis and septic arthritis were associated with higher platelet counts than other infections (P < .0001). Thrombocytosis secondary to infections was significantly more common in children under 5 years of age, whereas chronic inflammation, malignancy, and renal disorders were more common causes of thrombocytosis in children over 5 years of age. Thrombocytosis of 1 million or more platelets was seen in 13 (2%) children. No thrombocytosis-related complications were seen in any children, and none required any specific treatment. Thrombocytosis is a frequent finding in children. It is due to a variety of etiologic factors and is of little clinical discriminatory value. It is often due to an acute-phase phenomenon in response to infection, tissue damage, blood loss, or anemia, and is rarely due to malignancy.


Assuntos
Trombocitose/etiologia , Reação de Fase Aguda , Adolescente , Criança , Pré-Escolar , Humanos , Lactente , Estudos Prospectivos
16.
J Infect ; 25(1): 11-9, 1992 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-1365011

RESUMO

Sixty-four consecutive febrile episodes in 50 consecutive patients with malignancy and neutropenia were empirically treated with a combination of ceftazidime and amikacin. Of 52 analysable episodes, the response rate was 59.6% overall and 26.3% of episodes with microbiologically documented infections with septicaemia. Infection-related death occurred in 10 patients (19.2% of episodes). The response rates were similar in patients with acute leukaemia or other malignancies. Poor response is attributed to increased frequency of infections with Gram-positive and fungal organisms. A modified empiric regimen including cover for Gram-positive and fungal organisms is suggested in similar patient populations.


Assuntos
Amicacina/uso terapêutico , Ceftazidima/uso terapêutico , Febre/tratamento farmacológico , Neutropenia/complicações , Adulto , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Hospitais Universitários , Humanos , Micoses/tratamento farmacológico , Neoplasias/complicações , Neutropenia/tratamento farmacológico , Arábia Saudita , Sepse/tratamento farmacológico , Resultado do Tratamento
17.
J Intern Med ; 229(6): 493-5, 1991 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2045755

RESUMO

A total of 777 patients with thrombocytosis, defined as a platelet count of greater than 500 x 10(9)l-1, seen in a University hospital over a 1-year period, were studied prospectively for aetiology. The most frequent causes of thrombocytosis were infection (21.9%), rebound thrombocytosis (19.4%), tissue damage (17.9%), chronic inflammatory disorders (13.1%) and malignancy (5.9%). Thrombocytosis associated with multiple causative factors, occurring simultaneously, was seen in 6.1% of cases. Thrombocytosis of greater than or equal to 1 million x 10(9)l-1 was found most frequently in patients with multiple aetiological factors occurring at the same time, in myeloproliferative disorders, or in postsplenectomy patients.


Assuntos
Trombocitose/etiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Infecções/complicações , Inflamação/complicações , Masculino , Pessoa de Meia-Idade , Neoplasias/complicações , Contagem de Plaquetas , Estudos Prospectivos , Recidiva , Procedimentos Cirúrgicos Operatórios/efeitos adversos , Trombocitose/sangue
18.
Respir Med ; 85(1): 81-3, 1991 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-2014364

RESUMO

We report a case of spontaneous bilateral pneumothoraces due to metastatic choriocarcinoma. The patient was successfully treated with tube thoracostomy and chemotherapy. Pneumothorax as a complication of choriocarcinoma has not been reported previously.


Assuntos
Coriocarcinoma/secundário , Neoplasias Pulmonares/secundário , Pneumotórax/etiologia , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Coriocarcinoma/complicações , Coriocarcinoma/tratamento farmacológico , Cisplatino/administração & dosagem , Etoposídeo/administração & dosagem , Feminino , Humanos , Neoplasias Pulmonares/complicações , Neoplasias Pulmonares/tratamento farmacológico , Pneumotórax/cirurgia , Toracostomia , Neoplasias Uterinas/patologia
19.
Ann Saudi Med ; 11(1): 97-9, 1991 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17588066
20.
Arch Dermatol ; 126(12): 1617-20, 1990 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2256687

RESUMO

A case of Langerhans' cell histiocytosis with unusual skin manifestations in the form of multiple large skin tumors is described. The skin lesions responded partially to chemotherapy with etoposide and prednisone, and residual lesions were excised surgically. The patient developed central diabetes insipidus during treatment.


Assuntos
Histiocitose de Células de Langerhans/patologia , Neoplasias Primárias Múltiplas/patologia , Neoplasias Cutâneas/patologia , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Terapia Combinada , Etoposídeo/administração & dosagem , Histiocitose de Células de Langerhans/terapia , Humanos , Masculino , Neoplasias Primárias Múltiplas/terapia , Prednisona/administração & dosagem , Neoplasias Cutâneas/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...